Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)

KOSDAQ:318160 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	64,745	66,620	27,645	37,862	-	-
Market Cap Growth	87.38%	140.98%	-26.98%	-	-	-
Enterprise Value	71,361	62,798	17,671	33,014	-	-
Last Close Price	7730.00	8170.00	3150.00	4090.00	-	-
PE Ratio	7.28	7.64	6.31	-	-	-
PS Ratio	1.27	1.31	0.97	1.39	-	-
PB Ratio	1.10	1.13	0.60	0.85	-	-
P/TBV Ratio	1.18	1.22	0.62	0.88	-	-
P/FCF Ratio	-	-	3.82	33.46	-	-
P/OCF Ratio	43.55	44.81	2.98	21.52	-	-
EV/Sales Ratio	1.40	1.23	0.62	1.21	-	-
EV/EBITDA Ratio	6.07	5.34	2.97	6.67	-	-
EV/EBIT Ratio	7.66	6.74	4.38	10.48	-	-
EV/FCF Ratio	-13.85	-	2.44	29.18	-	-
Debt / Equity Ratio	0.35	0.35	0.09	0.13	0.14	0.38
Debt / EBITDA Ratio	1.75	1.75	0.68	1.20	0.97	2.05
Debt / FCF Ratio	-	-	0.56	5.24	67.51	3.77
Net Debt / Equity Ratio	0.07	0.07	-0.22	-0.17	-0.04	-0.17
Net Debt / EBITDA Ratio	0.33	0.33	-1.72	-1.53	-0.31	-0.94
Net Debt / FCF Ratio	-0.76	-0.76	-1.41	-6.68	-21.46	-1.73
Asset Turnover	0.72	0.72	0.54	0.55	0.53	0.66
Inventory Turnover	3.50	3.50	3.02	2.25	2.59	4.69
Quick Ratio	1.43	1.43	2.92	2.08	1.29	2.61
Current Ratio	2.29	2.29	3.82	3.15	2.57	3.34
Return on Equity (ROE)	16.50%	16.50%	9.63%	-4.49%	7.52%	7.51%
Return on Assets (ROA)	8.24%	8.24%	4.76%	3.97%	4.25%	6.62%
Return on Invested Capital (ROIC)	16.23%	18.20%	9.31%	8.58%	8.43%	12.13%
Return on Capital Employed (ROCE)	13.50%	13.50%	8.70%	7.10%	9.20%	11.60%
Earnings Yield	13.47%	13.09%	15.84%	-4.91%	-	-
FCF Yield	-7.96%	-7.73%	26.21%	2.99%	-	-
Buyback Yield / Dilution	8.00%	8.00%	-5.59%	-20.68%	11.32%	1.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.